These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 21377283)
1. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283 [TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504 [TBL] [Abstract][Full Text] [Related]
4. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Aslani M; Sultanem K; Voung T; Hier M; Niazi T; Shenouda G Head Neck; 2007 Jun; 29(6):585-90. PubMed ID: 17274051 [TBL] [Abstract][Full Text] [Related]
5. Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary. Hauswald H; Lindel K; Rochet N; Debus J; Harms W Strahlenther Onkol; 2008 Mar; 184(3):150-6. PubMed ID: 18330511 [TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
8. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340 [TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related]
10. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318 [TBL] [Abstract][Full Text] [Related]
11. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420 [TBL] [Abstract][Full Text] [Related]
12. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Rusthoven KE; Raben D; Schneider C; Witt R; Sammons S; Raben A Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1365-70. PubMed ID: 19168295 [TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383 [TBL] [Abstract][Full Text] [Related]
15. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453 [TBL] [Abstract][Full Text] [Related]
16. Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes. Doty JM; Gossman D; Kudrimoti M; Valentino J; Arnold S; Spring PM J Ky Med Assoc; 2006 Feb; 104(2):57-64. PubMed ID: 16594571 [TBL] [Abstract][Full Text] [Related]
17. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Maulard C; Housset M; Brunel P; Huart J; Ucla L; Rozec C; Delanian S; Baillet F Laryngoscope; 1992 Aug; 102(8):884-90. PubMed ID: 1495353 [TBL] [Abstract][Full Text] [Related]
18. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283 [TBL] [Abstract][Full Text] [Related]
19. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98]. Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]